ESG Inc. Files S-1/A Amendment
Ticker: ESGH · Form: S-1/A · Filed: Oct 9, 2024 · CIK: 1883835
Sentiment: neutral
Topics: sec-filing, s-1/a, company-update
TL;DR
ESG Inc. (formerly PLASMA INNOVATIVE INC.) filed an S-1/A on 10/9/24. Bio products co. in PA.
AI Summary
ESG Inc. filed an S-1/A amendment on October 9, 2024, detailing its financial status. The company, formerly known as PLASMA INNOVATIVE INC. until September 20, 2021, operates in the biological products sector. Its fiscal year ends on December 31, and its principal business address is in Kennett Square, PA.
Why It Matters
This filing provides updated information for investors and the public regarding ESG Inc.'s financial health and corporate structure, crucial for understanding its current market position and future prospects.
Risk Assessment
Risk Level: medium — As an S-1/A filing, it indicates a company preparing for or undergoing significant corporate actions like an IPO or major financial restructuring, which inherently carries risk.
Key Numbers
- 2024 Q2 — Reporting Period (Financial data presented is for the second quarter of 2024.)
- 1231 — Fiscal Year End (The company's fiscal year concludes on December 31st.)
Key Players & Entities
- ESG Inc. (company) — Filer
- PLASMA INNOVATIVE INC. (company) — Former company name
- 20210920 (date) — Date of name change
- 267-467-5871 (phone_number) — Business phone number
- 523 SCHOOL HOUSE RD (address) — Business and mailing address
- KENNETT SQUARE (location) — City for business and mailing address
- PA (location) — State for business and mailing address
- 19348 (zip_code) — ZIP code for business and mailing address
- 0001520138-24-000332 (filing_id) — Accession number for the filing
- 20241009 (date) — Filing date
FAQ
What is the primary business of ESG Inc.?
ESG Inc. is in the business of Biological Products (No Diagnostic Substances), with SIC code 2836.
When did ESG Inc. change its name?
The company changed its name from PLASMA INNOVATIVE INC. on September 20, 2021.
Where is ESG Inc. located?
ESG Inc.'s business and mailing address is 523 SCHOOL HOUSE RD, KENNETT SQUARE, PA 19348.
What is the accession number for this S-1/A filing?
The accession number for this filing is 0001520138-24-000332.
What is the SEC file number associated with this filing?
The SEC file number is 333-281681.
Filing Stats: 4,679 words · 19 min read · ~16 pages · Grade level 13.8 · Accepted 2024-10-09 10:47:36
Key Financial Figures
- $5.00 — f Common Stock Offered by the Company $5.00 per share The registrant hereby amend
- $0.001 — offering of our common stock, par value $0.001 per share. We are selling 5,000,000 sha
- $20,000 — ed States to AUFP, for a monthly fee of $20,000. AUFP paid ESG Inc. $60,000 on January
- $60,000 — thly fee of $20,000. AUFP paid ESG Inc. $60,000 on January 18, 2024 for the first quart
- $180,000 — 4 for the third quarter, for a total of $180,000. The Consulting Agreement is attached a
- $3,604,169 — selling to AUM at market price totaled $3,604,169, in 2023, and,$3,814,879 in 2022. Separ
- $3,814,879 — price totaled $3,604,169, in 2023, and,$3,814,879 in 2022. Separately, revenue earned by
- $1,519,838 — by AUMT when selling to AUM at cost was $1,519,838 for the six months ended June 30 2024.
Filing Documents
- esgh-20241008_s1a.htm (S-1/A) — 1471KB
- image_01.jpg (GRAPHIC) — 22KB
- image_02.jpg (GRAPHIC) — 101KB
- image_03.jpg (GRAPHIC) — 67KB
- 0001520138-24-000332.txt ( ) — 6433KB
- esgh-20240630.xsd (EX-101.SCH) — 41KB
- esgh-20240630_cal.xml (EX-101.CAL) — 63KB
- esgh-20240630_def.xml (EX-101.DEF) — 125KB
- esgh-20240630_lab.xml (EX-101.LAB) — 274KB
- esgh-20240630_pre.xml (EX-101.PRE) — 237KB
- esgh-20241008_s1a_htm.xml (XML) — 924KB
RISK FACTORS
RISK FACTORS 13 CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS 36
USE OF PROCEEDS
USE OF PROCEEDS 38 DETERMINATION OF THE OFFERING PRICE 39
DILUTION
DILUTION 40 MARKET FOR REGISTRANT'S COMMON STOCK, DIVIDEND POLICY AND RELATED STOCKHOLDER MATTERS 41
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 42 MANAGEMENT, DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 47 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 57 PLAN OF DISTRIBUTION 59
DESCRIPTION OF CAPITAL STOCK
DESCRIPTION OF CAPITAL STOCK 60 EXPERTS 61 LEGAL MATTERS 61 WHERE YOU CAN FIND MORE INFORMATION 61 INDEX TO FINANCIAL STATEMENTS F-1 i ABOUT THIS PROSPECTUS In making your investment decision, you should only rely on the information contained in this prospectus. We have not authorized anyone to provide you with any other or different information. If anyone provides you with information that is different from, or inconsistent with, the information in this prospectus, you should not rely on it. We believe the information in this prospectus is materially complete and correct as of the date on the front cover. We cannot, however, guarantee that the information will remain correct after that date. For that reason, you should assume that the information in this prospectus is accurate only as of the date on the front cover and that it may not still be accurate on a later date. This document may only be used where it is legal to sell these securities. The information contained in this prospectus is current only as of its date, regardless of the time of delivery of this prospectus or of any sales of our shares of common stock. You should not interpret the contents of this prospectus to be legal, business, investment or tax advice. You should consult with your own advisors for that type of advice and consult with them about the legal, tax, business, financial and other issues that you should consider before investing in our common stock. This prospectus does not offer to sell, or ask for offers to buy, any shares of our common stock in any state or other jurisdiction in which such offer or solicitation would be unlawful or where the person making the offer is not qualified to do so. No action is being taken in any jurisdictions outside the United States to permit a public offering of our common stock or possession or distribution of this prospectus in those jurisdictions. Persons who come into possession of this prospectus in jurisdictions outside the Uni